Your browser doesn't support javascript.
loading
Bradykinin-bradykinin receptor (B1R) signalling is involved in the blood-brain barrier disruption in moyamoya disease.
Wang, Haidong; Sun, Wenxue; Li, Fengfeng; Jiang, Pei; Wang, Lei; Zhou, Nannan; Feng, Lei.
Afiliación
  • Wang H; Department of Pharmacy, The Affiliated Lianyungang Hospital of Xuzhou Medical University/The First People's Hospital of Lianyungang/First Affiliated Hospital of Kangda College of Nanjing Medical University, Lianyungang, China.
  • Sun W; Translational Pharmaceutical Laboratory, Jining First People's Hospital, Shandong First Medical University, Jining, China.
  • Li F; Institute of Translational Pharmacy, Jining Medical Research Academy, Jining, China.
  • Jiang P; Department of neurosurgery, Tengzhou Central People's Hospital, Jining Medical University, Tengzhou, China.
  • Wang L; Translational Pharmaceutical Laboratory, Jining First People's Hospital, Shandong First Medical University, Jining, China.
  • Zhou N; Institute of Translational Pharmacy, Jining Medical Research Academy, Jining, China.
  • Feng L; Translational Pharmaceutical Laboratory, Jining First People's Hospital, Shandong First Medical University, Jining, China.
J Cell Mol Med ; 27(24): 4069-4079, 2023 12.
Article en En | MEDLINE | ID: mdl-37818853

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Receptores de Bradiquinina / Enfermedad de Moyamoya Límite: Animals / Humans Idioma: En Revista: J Cell Mol Med Asunto de la revista: BIOLOGIA MOLECULAR Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Receptores de Bradiquinina / Enfermedad de Moyamoya Límite: Animals / Humans Idioma: En Revista: J Cell Mol Med Asunto de la revista: BIOLOGIA MOLECULAR Año: 2023 Tipo del documento: Article País de afiliación: China